Fundraising Fox

Gaorong Capital

Venture capital

Beijing · Seed–Series B · 4 people tracked

Fox Verdict
Sign up to see your fit
Stage
Seed–Series B
HQ
Beijing, CN
Instruments
Equity
Founded
2013
AUM
$2.2B
Tracked investments
3

Team · 4 people

from the firm's website

What they invest in

from 2 of 3 portfolio companies

AI & Machine Learning ×1Biotech ×1Cybersecurity ×1Deep Tech ×1GovTech ×1

HQs:United States×2

Investments · 3 tracked

founders shown can be your intro path
Archonarchon.bio

Archon Biosciences develops a computational protein design platform leveraging AI and deep learning for therapeutic and vaccine applications. The company was founded in 2023 by James Lazarovits and George Ueda, Ph.D., building on research in AI-driven protein engineering and nanomaterial delivery.

AI & Machine LearningBiotechDeep TechSeattle, US

George Ueda, Ph.D.(Chief Technology Officer, Co-Founder)James Lazarovits, Ph.D.(Chief Executive Officer, Co-Founder)

Archonarchon.incin𝕏

Archon provides compliance services that accelerate the federal authorization process for software vendors selling to government agencies, reducing typical timelines and associated expenses.

CybersecurityGovTechSan Francisco, US

George Parks(Founder and CEO)in

Frequently asked questions

What stage does Gaorong Capital invest at?
Gaorong Capital invests at the Seed, Series A, Series B stages.
What sectors does Gaorong Capital focus on?
Gaorong Capital focuses on Biotech, Consumer, Data & Infrastructure, EdTech, Enterprise Software, Fintech, FoodTech, Healthtech, Media & Entertainment, Medical Devices, Retail Tech, SaaS, Semiconductors.
Where is Gaorong Capital located?
Gaorong Capital is headquartered in Beijing, CN.

Similar investors

Featured in lists